# Caribou Biosciences, Inc. (CRBU): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/crbu for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Caribou Biosciences, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to pioneering genome-edited allogeneic cell therapies. These cutting-edge treatments are engineered to address both hematologic malignancies (blood cancers) and solid tumors, serving patients across the United States and internationally. Among its primary therapeutic candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy currently undergoing Phase 1 clinical trials for relapsed or refractory B cell non-Hodgkin lymphoma, and CB-011, an allogeneic anti-BCMA CAR-T cell therapy targeting relapsed...

## Quote & Key Metrics

As of 2026-10-26:

| Metric | Value |
|---|---|
| Price | $0.49 USD |
| Market Cap | $52.8M |
| P/E (TTM) | — |
| EPS (TTM) | −$1.08 |
| 52-Week Range | $0.44 – $3.54 |
| Dividend Yield (TTM) | — |

## Dividend

CRBU has no dividend payment history in our records.

## Frequently Asked Questions

### What does Caribou Biosciences, Inc. do?

Caribou Biosciences, Inc. (CRBU) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is CRBU's market cap?

Caribou Biosciences, Inc. (CRBU) has a market capitalization of approximately $52.8 million, as of October 26, 2026, based on the most recent share price and shares outstanding.

### Does CRBU pay a dividend?

No, Caribou Biosciences, Inc. (CRBU) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is CRBU profitable?

Caribou Biosciences, Inc. (CRBU) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has CRBU ever paid a dividend?

No. Dividend Data's records show no dividend payments from Caribou Biosciences, Inc. (CRBU). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/crbu
- Dividend history & safety: https://www.dividenddata.com/stocks/crbu/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/crbu/earnings
- Financial statements: https://www.dividenddata.com/stocks/crbu/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/crbu/valuation
- Peer comparison: https://www.dividenddata.com/stocks/crbu/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.